Background The CRASH-2 trial showed that early administration of tranexamic acid (TXA) safely reduces mortality in bleeding in trauma patients. Based on data from the CRASH-2 trial, global mortality ...

Research has revealed that many trauma patients have been receiving tranexamic acid without displaying any data-driven indication for the medication, according to an Aug. 17 report from Anesthesiology ...

VALDOSTA, Ga. (WALB) - Trauma is the leading cause of death for children and adults under the age of 44, according to the CDC. To tackle such a problem in Lowndes County, the South Georgia Medical ...

For patients undergoing surgery for elbow trauma, treatment with the hemostatic drug tranexamic acid (TXA) is associated with a decreased incidence of heterotopic ossification (HO) – a common ...

A recent study found that the drug tranexamic acid has minimal impact in controlling blood loss in severely injured trauma patients at the standard doses given, according to researchers at Washington ...

Please provide your email address to receive an email when new articles are posted on . Tranexamic acid may be indicated for the prevention of heterotopic ossification. Patients undergoing surgery for ...

A drug currently used to reduce bleeding in operating theatres and in trauma in the armed forces is set to be used by a civilian ambulance service for the first time in the UK, thanks to collaboration ...

A systematic review and meta-analysis show that tranexamic acid for bleeding significantly lowers mortality at 1 month after traumatic injury and traumatic brain injury, according to a new study in ...

TXA is an inexpensive (approximately $3 per gram) and widely available antifibrinolytic medication with an established safety ...

June 21, 2023 – For patients undergoing surgery for elbow trauma, treatment with the hemostatic drug tranexamic acid (TXA) is associated with a decreased incidence of heterotopic ossification (HO) – a ...